Paul M. Thompson
Proceedings Volume Medical Imaging 2023: Image Processing, 124640G https://doi.org/10.1117/12.2664587
Since 2009, we have led the ENIGMA Consortium, a worldwide alliance of over 2,000 scientists studying 30 brain diseases in 45 countries. Pooling multimodal brain images and genomic data from over 100,000 people worldwide, ENIGMA's 51 working groups have published the largest neuroimaging studies of schizophrenia, bipolar disorder, depression, PTSD, addiction, and Parkinson’s disease, OCD, ADHD, epilepsy, HIV and autism. ENIGMA’s genomic screens of more than 70,000 people’s brain scans and genome-wide data have brought together experts from 300 institutions to unearth genetic variants that affect brain structure, connectivity, functional brain synchrony, and disease risk. In this talk, we cover current and future challenges in analyzing medical imaging and genomic data worldwide. We describe the vast power of AI and deep learning methods for disease diagnosis, subtyping, and staging, and for discovering environmental, medication, and genomic factors that promote or resist disease. We illustrate the talk with mathematical examples from meta-analysis, AI and federated algorithms for multimodal image harmonization, predictive modeling, and even novel image synthesis and enhancement.